Header Logo

Connection

OLIVE ECKSTEIN to Rituximab

Back to Details
This is a "connection" page, showing publications OLIVE ECKSTEIN has written about Rituximab.
OLIVE ECKSTEIN
Connection Strength
0.557
Rituximab
  1. Rituximab therapy for patients with Langerhans cell histiocytosis-associated neurologic dysfunction. Pediatr Hematol Oncol. 2018 Oct - Nov; 35(7-8):427-433.
    View in: PubMed
    Score: 0.557
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.